US FDA Approves Aston Sci.'s Phase 2 IND for Ovarian Cancer Vaccine, AST-201
/PRNewswire/ -- Aston Sci. is proud to announce that it has received Phase 2 Clinical Investigational New Drug (IND) approval from the U.S. Food and Drug...
Source: prnewswire.com